Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Permethrin-Treated Baby Wraps for The Prevention of Malaria in Refugee Settings

NCT07903324 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT07903324 Not yet recruiting Not applicable 1,350 participants (estimated) Started 2027 1 site

Follow this trial by email Email me the PDF

Get the NCT07903324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Summary

Not yet recruiting, started September 2027. Interventional study, 1,350 participants (estimated). Lead sponsor University of North Carolina, Chapel Hill; Uganda. Primary measure: Incidence of clinical malaria in children.

How it compares

63 similar trials: same condition (Malaria, Falciparum) and phase

Enrollment

This trial
1,350
Middle half
40 to 2,430
Median
400
Trials with a value
61

Months from start to completion

This trial
36
Middle half
10.3 to 37
Median
20.9
Trials with a value
62

Sites

This trial
1
Middle half
1 to 1
Median
1
Trials with a value
61
Posted results or a linked paper 78% 49 of 63 similar trials; this trial: no

Registry record

As filed in ClinicalTrials.gov.

Title
Permethrin-Treated Baby Wraps for The Prevention of Malaria in Refugee Settings
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2027
Completion date
September 1, 2030
Enrollment
1,350 (estimated)
Sites
1

Conditions

MeSH condition names; the registry's own terms follow.

Malaria, Malaria, Falciparum

Registry terms: malaria (plasmodium falciparum), malaria incidence

Who could take part, where it ran, who ran it

As filed in ClinicalTrials.gov.

Sex
All
Minimum age
3 Months
Maximum age
99 Years
Healthy volunteers
Yes
Study type
Interventional
Sites
1
Countries
Uganda
Lead sponsor
University of North Carolina, Chapel Hill

Arms

As registered; 3 arms.

Registered arms
Arm Type Interventions
Receives factory-treated permethrin lesu Experimental Factory-treated lesu
Show registry wording

Receives factory-treated (0.52%) permethrin-treated wrap for 6 months

Receives soaked permethrin lesu Experimental Soaked lesu
Show registry wording

Receives soaked (1%) permethrin-treated wrap for 6 months

Receives untreated lesu Sham comparator Untreated lesu
Show registry wording

Receives the untreated lesu for 6 months

Primary endpoints

Registered primary outcome measures; 1 primary.

Registered primary endpoints
Measure Time frame
Incidence of clinical malaria in children From enrollment to Month 6
Show registry wording

Acute febrile illness defined as fever (temperature ≥38.0 Celsius) or fever reported in past 24 hours AND positive malaria rapid diagnostic test (RDT), confirmed by light microscopy (performed later), at scheduled or unscheduled study clinic visit

Lead sponsor's other trials

University of North Carolina, Chapel Hill, most recent start first.

Similar trials

Same condition (Malaria, Falciparum) and phase, most recent start first.